Improved Chemical and Radiochemical Synthesis of Neuropeptide Y Y2 Receptor Antagonist N-Methyl-JNJ-31020028 and Preclinical Positron Emission Tomography Studies
Open Access
- 8 April 2024
- journal article
- research article
- Published by MDPI AG in Pharmaceuticals
- Vol. 17 (4) , 474
Abstract
Neuropeptide Y (NPY) is one of the most abundant peptides in the central nervous system of mammals and is involved in several physiological processes through NPY Y1, Y2, Y4 and Y5 receptors. Of those, the Y2 receptor has particular relevance for its autoreceptor role in inhibiting the release of NPY and other neurotransmitters and for its involvement in relevant mechanisms such as feeding behaviour, cognitive processes, emotion regulation, circadian rhythms and disorders such as epilepsy and cancer. PET imaging of the Y2 receptor can provide a valuable platform to understand this receptor’s functional role and evaluate its potential as a therapeutic target. In this work, we set out to refine the chemical and radiochemical synthesis of the Y2 receptor antagonist N-[11C]Me-JNJ31020028 for in vivo PET imaging studies. The non-radioactive reference compound, N-Me-JNJ-31020028, was synthesised through batch synthesis and continuous flow methodology, with 43% and 92% yields, respectively. N-[11C]Me-JNJ-31020028 was obtained with a radiochemical purity > 99%, RCY of 31% and molar activity of 156 GBq/μmol. PET imaging clearly showed the tracer’s biodistribution in several areas of the mouse brain and gut where Y2 receptors are known to be expressed.Keywords
Funding Information
- Fundação para a Ciência e a Tecnologia (UIDB/00313/2020, UIDP/00313/2020, RECI/QEQ-QFI/0168/2012, CENTRO-07-CT62-FEDER-002012, PD/BDE/150334/2019)
- FEDER—European Regional Development Fund (UIDB/00313/2020, UIDP/00313/2020, RECI/QEQ-QFI/0168/2012, CENTRO-07-CT62-FEDER-002012, PD/BDE/150334/2019)
- Fundação para a Ciência e a Tecnologia (UIDB/00313/2020, UIDP/00313/2020, RECI/QEQ-QFI/0168/2012, CENTRO-07-CT62-FEDER-002012, PD/BDE/150334/2019)
This publication has 32 references indexed in Scilit:
- Rodent brain extraction and dissection: A comprehensive approachMethodsX, 2023
- The stability of the transcriptome during the estrous cycle in four regions of the mouse brainJournal of Comparative Neurology, 2017
- Microfluidics in radiopharmaceutical chemistryNuclear Medicine and Biology, 2013
- Neuropeptide Y, peptide YY and pancreatic polypeptide in the gut–brain axisNeuropeptides, 2012
- Optimization of [11C]DASB-synthesis: Vessel-based and flow-through microreactor methodsApplied Radiation and Isotopes, 2012
- In vitro and in vivo characterization of JNJ-31020028 (N-(4-{4-[2-(diethylamino)-2-oxo-1-phenylethyl]piperazin-1-yl}-3-fluorophenyl)-2-pyridin-3-ylbenzamide), a selective brain penetrant small molecule antagonist of the neuropeptide Y Y2 receptorPsychopharmacology, 2009
- Evidence from knockout mice for distinct implications of neuropeptide-Y Y2 and Y4 receptors in the circadian control of locomotion, exploration, water and food intakeNeuropeptides, 2009
- Neuropeptide Y does not reset the circadian clock in NPY Y2−/− miceNeuroscience Letters, 2005
- Blockade of central neuropeptide Y (NPY) Y2 receptors reduces ethanol self-administration in ratsNeuroscience Letters, 2002
- Identification and Distribution of mRNA Encoding the Y1, Y2, Y4, and Y5 Receptors for Peptides of the PP-fold Family in the Rat Intestine and ColonBiochemical and Biophysical Research Communications, 1998